ArticleAntibodies (Basel, Switzerland)2024

Development of BCMA-Targeted Bispecific Natural Killer Cell Engagers for Multiple Myeloma Treatment.

Minchuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.